Skip to main content
Caplight Logo









LenSense Inc.

LenSense Inc.

Private
KingstonHealthcare & Life Scienceshttps://lensense.ca

Last Round

Grant

Apr 28, 2025

Total Funding Raised

$537,000

Company Overview

LenSense Inc. operates in Healthcare & Life Sciences and is based in Kingston. Its latest recorded funding round was a Grant round in April 2025.

LenSense Inc. is a health-tech company that develops non-invasive, contact lens-based systems for continuous intraocular pressure monitoring to aid in the diagnosis and management of glaucoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

LenSense Inc. Comparables

Compare LenSense Inc. with similar companies based on industry and business-model similarity.

LenSense Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Smartlens
90%
BVS Sight Inc.
89%
GlakoLens
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

LenSense Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 28, 2025
GrantApr 1, 2025
GrantMar 1, 2024
SeedJun 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

LenSense Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2025

    $437K raised from Canadian Institutes of Health Research.

Book a demo to see all signals

For institutional investors. Book with your work email.

LenSense Inc. Filings

Explore SEC and related filing metadata, where available.

LenSense Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about LenSense Inc.'s valuation, stock price, and market status.

Is LenSense Inc. a public or private company?

LenSense Inc. is a private company.

What is the current stock price of LenSense Inc.?

LenSense Inc. is a private company, so its shares have no public market price. Caplight tracks LenSense Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is LenSense Inc. worth (valuation)?

Valuation information for LenSense Inc. is not publicly available.

Can I buy LenSense Inc. stock?

LenSense Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was LenSense Inc.'s last funding round?

LenSense Inc.'s most recent funding round was Grant on April 28, 2025.

Who are the main investors in LenSense Inc.?

Key investors in LenSense Inc. include Canadian Institutes of Health Research, Queen's University at Kingston, i.d.e.a. Fund, TIAP.

Will LenSense Inc. IPO soon?

No public IPO plans have been announced for LenSense Inc..

How can I track LenSense Inc. secondary market activity?

Caplight tracks bids, offers, and trades in LenSense Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersKingston
Employee Range1
Year Founded2022
Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?